chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a patient who was vaccinated with Varivax (Merck). Subsequently, the patient developed 20 to 30 pox. Unspecified medical attention was sought. The outcome was reported as recovered. No additional information to report. There was no product quality complaint involved. Additional information has been requested. No further information is expected.
24 hours after vaccine, hard lump, swollen and pink,  moderate chills. The next day, bigger lump, swollen, all just below injection and red, moderate chills, a bit itchy, nausea., and painful. Same on 3rd day but much bigger redness spreading down arm, 2 1/2 by 2 1/2' hard mass and red, itchy, painful, chills and nausea. Next morning called Dr. I am taking amoxicillin-clav 875-125ng tab.  Three days later mass is turning from red to pink and retreating. Still hurts  and now bruses show around the injection site, which I thought was strange. The vaccine actually hurt when given (I get injections every three months, so I know what they will feel like, but this hurt and went very deeply and then burned). I felt warm afterwards for about 10 minutes.
Information has been received from a registered nurse concerning a 65-year-old male who on 30-JAN-2006(Lot # 651434/0504R), 02-MAR-2006 (Lot # 651494/0504R), and 03-JUL-2006 (Lot # 650889/0143R) was vaccinated with his first, second, and third doses of RECOMBIVAX HB. One year later (2007), the patient experienced negative titers. No additional information to report. There was no product quality complaint involved. It was noted that the reporter "would like a trace for the lot numbers provided". A standard lot check investigation was performed for Lot # 651494/0504R and Lot # 650889/0143R. All in-process quality checks for the lot numbers in question were satisfactory. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. This is one of three cases from the same source. Additional information has been requested.
pt recv vax 31JUL98 & 6AUG98 devel joint pain;seen by Md & treated w/ibuprofen;pain in getting worse;
Patient was in recovery area per protocol. Patient developed light headedness, diaphoresis, irritability and then collapsed into chair and then floor (helped by nursing staff) patient appeared unconscious but was breathing, oxygen applied, emergency response initiated
Moderate Local Reaction to Anthrax Vaccine #1: 1 week after receiving anthrax vaccination, developed warm, tender, edematous, erythematous ring around site of vaccination (R tricep) area that measured approximately 5 cm x 4.5 cm.  Ecchymotic area noted at distal edge.  No nodules palpable.  No streaking noted.  Of note, she also discovered she was pregnant 3 days after receiving anthrax vaccination.  As a result, we recommended conservative treatment with ice for 20 min (4-5 x day) over the next 24 hours, then may switch to heat for 20 minutes 4-5 x/day.
Pain left arm, redness from vaccination area to elbow. Swelling left arm to elbow, itching lasted 4-5 days, arm was very hot. Follow up: problem at pneumococcal site only.
EVENING OF PNEUOCOCCAL INJECTION ARM STARTED PAINING. NEXT DAY PAIN WAS SO BAD UNABLE TO LIFT ARM. TODAY ARM IS UPPER INNER ASPECT WAS RED AND WARM TO THE TOUCH.
Hives started 4 days after vaccination and I still have them as of June 27, 2021. Went to an allergist, he prescribed antihistamines, they are not working.  Waiting to see another doctor to get Xolair shots.
Patient was given immunization at 7:30am, at 7:50am she reported her hands were a little tingly. The patients blood pressure was taken 203/125. She then reported a dry mouth, feeling flush, and a little difficulty swallowing. 911 was called and her blood pressure was monitored. 7:56am 181/108 HR65, 7:59am 184/98 HR 57 8:03am 189/110 HR 62. EMS arrived and took over. EMS transported patient to the hospital to be monitored due to blood pressure.
Approx. 10  days post vaccination, HCW reports increased tiredness, generalized  joint and muscle pain.  Symptoms lasted for 48 hrs.   Took Advil with relief.  There were no evidence of a vaccine reaction at the injection site.  No redness, swelling or tenderness was noted.
Patient complained of sore left shoulder beginning on 10/05/2017. I recommended that the patient seek care from his primary care provider on 10/14/17.
Information has been received from a medical assistant concerning a male office administrator who on 02-SEP-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot # 662905/1162X). On the same day 02-SEP-2009 his wife received a dose of PNEUMOVAX 23 (lot # 662905/1162X). On an unspecified date he was having chills and her temperature was 100.6 degrees. The arm which was vaccinated was achy, red, had red streaks and looked it had cellulitis. It hurt to move that arm. The arm was warm to the touch and felt like a softball. He also experienced a headache. The patient's outcome was unknown. His wife had no symptoms. This is one of two reports from the same source. Additional information has been requested.
Patient reported after receiving the vaccine that their arm hurt (felt like a "shooting pain") and the pain did not dull or go away. The pain traveled to the patients neck and head. They also reported that they did not feel like eating and felt they could not concentrate or "felt out of it".
her menstrual period began the day following the second covid vaccination (on 28Mar2021), which was one week early; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 27Mar2021 09:00 (Batch/Lot Number: EN6206) as 2ND DOSE,SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose, of  bnt162b2 (lot number:EN6206) on 06Mar2021 at 09:00 AM in the left arm for covid-19 immunization. The patient stated that her menstrual period began the day following the second covid vaccination (on 28Mar2021), which was one week early. The patient have never started that early before. The outcome of event was unknown. Patient did not receive any treatment for the event  No follow-up attempts are needed. No further information is expected.
Pain and lumps and tightness in armpit and breast of the arm that recieved the shot
By 3pm a migraine occurred. Migraines continued to cycle for the whole week. Around 4pm-5pm the day of the shot a minor panic attack occurred for about 30 min. No medications were taken for panic attack. Nurtec and Excedrin was taken to deal with migraine attacks along with sleep during course of the week. I was unable to maintain other routine doctor appointments that week as a result.
This spontaneous report has been received from a pharmacist and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. It was reported by the pharmacist that on 10-MAR-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (dose, route of administration, and frequency were not reported), for prophylaxis. A digital data logger was used. No adverse effects were reported. This is one of multiple reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA014153: US-009507513-1706USA001720: Original Case: 1706USA001714 US-009507513-1706USA001721: Original Case : 1706USA001714 US-009507513-1706USA001722: Original Case : 1706USA001714 US-009507513-1706USA001723: Original Case : 1706USA001714 US-009507513-1706USA001719: Original Case : 1706USA001714 US-009507513-1706USA001714: Original Case : 1706USA001714 US-009507513-1706USA001725: Original Case : 1706USA001714 US-009507513-1706USA001726: Original Case : 1706USA001714 US-009507513-1706USA001727: Original Case : 1706USA001714 US-009507513-1706USA001728: Original Case : 1706USA001714 US-009507513-1706USA001729: Original Case : 1706USA001714.
This spontaneous report was received from a physician via field representative and refers to a 14 year old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date in 2017 (reported as 5 months ago), the patient was vaccinated with first dose of GARDASIL 9 (site and route of administration, lot # and expiration date were not reported). On an unknown date in 2017, the patient experienced hallucination. No treatment was given for the adverse events. It was unknown if the patient was hospitalized. The outcome of the event and the relatedness between the event and GARDASIL 9 were not reported. Additional information has been requested.
1 week after my first vaccination I had a rash which covered my injection site arm.; fatigued, tired after her first vaccination; My injection site arm was sore for 3 days after the vaccination.; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigued, tired after her first vaccination), VACCINATION SITE PAIN (My injection site arm was sore for 3 days after the vaccination.) and VACCINATION SITE RASH (1 week after my first vaccination I had a rash which covered my injection site arm.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Oct-2021, the patient experienced FATIGUE (fatigued, tired after her first vaccination) and VACCINATION SITE PAIN (My injection site arm was sore for 3 days after the vaccination.). On 26-Oct-2021, the patient experienced VACCINATION SITE RASH (1 week after my first vaccination I had a rash which covered my injection site arm.). At the time of the report, FATIGUE (fatigued, tired after her first vaccination), VACCINATION SITE PAIN (My injection site arm was sore for 3 days after the vaccination.) and VACCINATION SITE RASH (1 week after my first vaccination I had a rash which covered my injection site arm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter  No Treatment Information were provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Follow-up received contains
Less than one hour after receiving my first Moderna vaccine I started to develop a slight red rash from my neck down my stomach and onto my legs. The rash developed into hives in less than 12 hours. I had hives that resembled bee stings from my neck down my torso and onto my legs. The rash burned like fire and was slightly itchy. I had to take Benadryl for 3 days to lessen the symptoms. After about three days the rash and hives started to dissipate.
Redness, swelling, pain, warmth at injection site. Per patient, MD said it was an infection at injection site. Patient was given CIPRO 500mg and DICLOFENAC 75mg.
This spontaneous report was received from a registered nurse refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On unspecified dates, the patients were vaccinated with improperly stored VARIVAX with lots # M023379, expiry date 11-MAY-2018 or lot # M010482 and expiry date 01-MAR-2018 (dose, strength, vaccination site, route unspecified). No adverse effect were reported. Product quality complain (PQC) was not involved. No further information was provided. Additional information has been requested.
Within two weeks of my vaccine I had itching and discomfort around the hair follicles in my eyebrows. My scalp was itching and I had a rash around my eyebrows. I was given a steroid desonide cream and it cleared up the rash around my eyebrows but my scalp was still itchy. The rash is dry flaky and has red bumps and it looks inflamed. The inflammation returned as soon as stopped using the steroid the rash returned. I have been prescribed Temovate to see if that works better. The rash on my head was visible around my eyes and nose. My hair is starting to thin at the crown of my head and the part along the crown. My eyebrows have also gotten thinner. I am being screened for an auto immune inflammatory disorder called Lichen planopilaris. They have performed a biopsy on 6/23/2021 at the crown of my head which has the most inflammation. I am waiting on results.
minor itch started on arms and elbows, the on inner thighs, as days passed little bumps red rash started to pop up it just worst, and very itchy and red rash
Redness began in my left arm 9 days after the injection. The redness is not painful and does not bother me but it is warm to the touch. It is still red and warm as of 1/4/21.
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported Pharmacist reported that they gave 26 doses after the 30-day use by date. Pharmacist would like to know if those doses were viable or not. Number of doses/vials: 26 Date the vial was initially stored in the refrigerator : 14Jan2022  Date(s) of administration of vaccine: 14Feb2022, 15Feb2022, 16Feb2022, 18Feb2022, 21Feb2022.Vial did not undergo any temperature excursions.  No treatment information was reported. .
Vagal syncope- patient passed out, extreme sweating, some muscle twitching, slowing of pulse rate, loss of consciousness Laid patient on ground, propped legs up Duration of 10 minutes before fully regaining consciousness
vomiting & diarrhea on & off for 5 days. MD thought it was somewhat different than gastroentertis; Also had low-grade fever;
pt recv vax & exp bad head cold, watering eyes, runny nose, all the drainage was uncomfortable & kept in bed;last 2 days severe cough, flu type again, sore throat, drainage eyes, cough;
Flu symptoms (cough, runny nose, weak), itchy and red patches on back and face, swollen face
Vesicular rash in crops  over torso, extremities, Fever to 100 (rectally) Irritability, Pt seen in office 09/11/02, 50-100 spots seen.
Tested positive by PCR test 1 day prior to starting paxlovid treatment; Tested positive by PCR test 1 day prior to starting paxlovid treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ACETAMINOPHEN, start date: 07May2022, stop date: 11May2022; ADVIL [IBUPROFEN], start date: 07May2022, stop date: 11May2022. Past drug history included: Amoxicillin, reaction(s): "Known allergies: amoxicillin"; Ceclor, reaction(s): "Known allergies: ceclor". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 08May2022, outcome "unknown" and all described as "Tested positive by PCR test 1 day prior to starting paxlovid treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08May2022) Positive, notes: Tested positive by PCR test; (16May2022) Negative, notes: Tested negative on antigen test; (20May2022) Positive, notes: Cough symptoms developed on day 13 with strong positive antigen test. Clinical course: Symptoms included fever, bad body aches and chills, sore throat. Patient received Paxlovid from 09May2022, to 13May2022 for the treatment of Covid-19. Symptoms disappeared over course of treatment. Tested negative on antigen test day 7 after initial positive test, for several days was fine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Developed pneumonia roughly three weeks after injection requiring heavy, broad spectrum antibiotics and  albuterol treatments.
Left shoulder is red, swollen and arm. Induration measured 8.5x10cm. Redness extended beyond these measurements 16.5x16cm. Pt advised by MD to watch swelling and redness. If inflammation increases in size and/or becomes painful, pt is to return to clinic. Pt advised to use Motrin or Tylenol for pain and swelling.
Have had residual muscle pain where I received my epidurals during childbirth 2 and 4 years ago.
I had to the Moderna Booster.  I wanted it to be noted in the system that I received my moderna booster on December 10, 2021.  Exactly 10 days after booster developed Redness and hives with dermatographia of the skin.  Generalized throughout my body and not specific to one location.  I have seen my primary care physician as well as an allergist appointment upcoming on 3/2/22  as recommended per doctor .  I have documented images of my skin, but I wanted it to be made aware that I have never had an issue with reactions or hives in the past only to this booster it has continued since
Muscle ache; Severe cramps in my legs; Teeth ache in my jaw, a severe one teeth aching; My eyes ran, were oozing; Pain in arm/I could feel the pain in my arm; The caller states she has been in severe pain since Feb; This is a spontaneous report from a contactable consumer or other non hcp.    A 80-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 25Feb2021 02:30 as dose 1, single for covid-19 immunisation The patient medical history concomitant medications was not reported. It was Reported, the caller is a consumer reporting she received both doses Pfizer Covid 19 Vaccine. The caller received the first dose Pfizer Covid 19 Vaccine on 25Feb2021 at (Withheld) and the second dose Pfizer Covid 19 Vaccine was received on 18Mar2021 also at (withheld). The doses of the Pfizer Covid 19 Vaccine were received 21 days or so apart. The caller has had severe adverse effects after receiving the Pfizer Covid 19 Vaccine. The caller can barely use her legs, the legs are in severe pain. The caller was a person that walked and exercised, walked 3 miles a day. The caller can barely get around, and up and down in the morning is hell. The caller is so weak, and the legs hurt so bad. The other effect is the caller's eyes swelled up and ran sticky oozy stuff. The caller went to the dermatologist and was given cortisone and after 14-15 days that cleared up, it was white. The caller went to her doctor about the pain in her legs. The caller is taking Tramadol and Ibuprofen and they are not a lot of help. The doctor said it will run its course. the patient experienced pain in arm/i could feel the pain in my arm, the caller states she has been in severe pain since feb, muscle ache, severe cramps in my legs, teeth ache in my jaw, a severe one tooth aching, my eyes ran, were oozing on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of the caller states she has been in severe pain since feb (pain). Follow-up (16Jul2021): This is a Follow-up spontaneous report from a contactable consumer. This consumer (patient) reported information included. Follow up (16Jul2021): This is a follow up spontaneous report from a contactable consumer. This 80-year-old female consumer (patient) reported in response to telephonic follow-up activity which included Follow up (31Jul2021): This is a Follow-up spontaneous report from a contactable consumer.  This 80-year-old female consumer (patient) reported information included.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Administer expired vaccine to 450 patients after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Health care professional (HCP) administered expired vaccine to 450 patients, after the manufacture date of expiration. Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses. Dates of administration of vaccine were reported as 10-Nov-2021 and 11-Nov-2021. The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live non significant follow-up received contains: Reporter details added.
Pt describes feeling fine when he initially recieved the vaccine, but after waking up from  a nap at 8 pm he noticed redness, a hard lump under his skin where he recieved the vaccine, and pain shooting  down his arm. It was about 12 hours from when he recieved the shot to when he noticed the symptoms. This is his third vaccine in the series and he did not notice any adverse effects with the first two.
Next day: tachycardia, short of breath, fatigue exerrtonal fatigue
rash and sore; rash and sore; A Spontaneous Report was received concerning a 82 Years old, Female patient who received Moderna's COVID-19 vaccine (mRNA-1273) 2 doses and experienced rash, sore,red rash, itchiness,      The patient's medical history is unknown     On 22/jan/2021 patient received first dose of mRNA-1273 of batch number-013L20A, and on 19/feb/2021 she received second dose of vaccination   Event or Problem With the first dose she got a rash and sore. The rash had the size of a quarter. Appeared a week after the first dose and lasted a couple of days. With the second dose had a red rash, sore, itching and it's bigger/ larger (3x3) than with the first shot. Noticed it on Saturday. rash is still there, the soreness is little less follow Up directly: Yes     Treatment information was given as With a hot compress it seems to be relieved  Action taken with mRNA-1273 in response to the events was not provided.     The outcome of the events were unknown